InsiderTrades

Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0001870913-24-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-06-20 2024-06-17+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $60.59 -30.0K 702.6K -4% -$1.82M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-17 S D 7,946 $61.41 724,674 I Held by Esjay LLC — — (F2) The shares were sold in multiple trades at prices ranging from $60.77 to $62.55. The price reported above reflects the weighted average sales price. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2024-06-18 S D 10,607 $60.76 714,067 I Held by Esjay LLC — — (F4) The shares were sold in multiple trades at prices ranging from $60.33 to $61.82. The price reported above reflects the weighted average sales price. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2024-06-20 S D 11,447 $59.86 702,620 I Held by Esjay LLC — — (F5) The shares were sold in multiple trades at prices ranging from $59.40 to $60.50. The price reported above reflects the weighted average sales price. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.